Celgene (CELG) Tops Q2 EPS by 4c, Raise FY EPS Guiadnce
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene (NASDAQ: CELG) reported Q2 EPS of $1.82, $0.04 better than the analyst estimate of $1.78. Revenue for the quarter came in at $3.27 billion versus the consensus estimate of $3.23 billion.
GUIDANCE:
Celgene sees FY2017 EPS of $7.25-$7.35.
Previous 2017 Guidance | Updated 2017 Guidance | |||
| Net Product Sales | ||||
| REVLIMID(®) | $8.0B to $8.3B | Unchanged | ||
| POMALYST(®)/IMNOVID(®) | Approximately $1.6B | Unchanged | ||
| OTEZLA(® ) | $1.5B to $1.7B | Unchanged | ||
| ABRAXANE(®) | Approximately $1.0B | Unchanged | ||
| Total Revenue | $13.0B to $13.4B | Unchanged | ||
| GAAP operating margin | Approximately 46.0% | Approximately 41.5% | ||
| GAAP diluted EPS | $5.95 to $6.29 | $5.36 to $5.62 | ||
| Adjusted operating margin | Approximately 57.0% | Approximately 57.5% | ||
| Adjusted diluted EPS | $7.15 to $7.30 | $7.25 to $7.35 | ||
| Weighted average diluted shares | Approximately 815M | Unchanged |
For earnings history and earnings-related data on Celgene (CELG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
- VNET Group (VNET) Misses Q2 EPS by 164c
- Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
